{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T02:47:18Z","timestamp":1791168438788,"version":"4.1.0"},"reference-count":138,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Stomatology Oral and Maxillofacial Surgery"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jormas.2025.102534","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T01:24:30Z","timestamp":1755653070000},"page":"102534","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"S","title":["Dual effects of bisphosphonates on bone metabolism and implant osseointegration: mechanisms, risks and clinical strategies"],"prefix":"10.1016","volume":"126","author":[{"given":"Hongqi","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinjing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueyi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanmei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengli","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yawen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jormas.2025.102534_bib0001","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0022-3913(83)80101-2","article-title":"Osseointegration and its experimental background","volume":"50","author":"Br\u00e5nemark","year":"1983","journal-title":"J Prosthet Dent"},{"issue":"1","key":"10.1016\/j.jormas.2025.102534_bib0002","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/prd.12176","article-title":"Initial and long-term crestal bone responses to modern dental implants","volume":"73","author":"Albrektsson","year":"2017","journal-title":"Periodontol 2000"},{"issue":"9","key":"10.1016\/j.jormas.2025.102534_bib0003","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.4065\/83.9.1032","article-title":"Bisphosphonates: mechanism of action and role in clinical practice","volume":"83","author":"Drake","year":"2008","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"10.1016\/j.jormas.2025.102534_bib0004","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jconrel.2013.01.032","article-title":"Biomedical applications of bisphosphonates","volume":"167","author":"Giger","year":"2013","journal-title":"J Control Release"},{"issue":"Suppl 2","key":"10.1016\/j.jormas.2025.102534_bib0005","doi-asserted-by":"crossref","first-page":"S163","DOI":"10.1542\/peds.2006-2023I","article-title":"Experience with bisphosphonates in osteogenesis imperfecta","volume":"119","author":"Glorieux","year":"2007","journal-title":"Pediatrics"},{"issue":"10","key":"10.1016\/j.jormas.2025.102534_bib0006","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/jbmr.5650101008","article-title":"Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo","volume":"10","author":"Hughes","year":"1995","journal-title":"J Bone Miner Res"},{"issue":"6","key":"10.1016\/j.jormas.2025.102534_bib0007","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.coph.2005.06.005","article-title":"Osteoprotegerin and RANKL regulate bone resorption, density, geometry and strength","volume":"5","author":"Kostenuik","year":"2005","journal-title":"Curr Opin Pharmacol"},{"issue":"2","key":"10.1016\/j.jormas.2025.102534_bib0008","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation","volume":"93","author":"Lacey","year":"1998","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.jormas.2025.102534_bib0009","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1006\/bbrc.2002.6510","article-title":"Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts","volume":"291","author":"Viereck","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.jormas.2025.102534_bib0010","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.bbrc.2004.12.145","article-title":"Nitrogen-containing bisphosphonate, YM529\/ONO-5920 (a novel minodronic acid), inhibits RANKL expression in a cultured bone marrow stromal cell line ST2","volume":"328","author":"Nishida","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.jormas.2025.102534_bib0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2045-824X-5-1","article-title":"Bisphosphonate-related osteonecrosis of jaw (BRONJ): diagnostic criteria and possible pathogenic mechanisms of an unexpected anti-angiogenic side effect","volume":"5","author":"Sharma","year":"2013","journal-title":"Vasc Cell"},{"issue":"1","key":"10.1016\/j.jormas.2025.102534_bib0012","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/FPC.0b013e328335729c","article-title":"Bisphosphonates pathway","volume":"21","author":"Gong","year":"2011","journal-title":"Pharmacogenet Genomics"},{"issue":"5","key":"10.1016\/j.jormas.2025.102534_bib0013","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/jop.12021","article-title":"Bisphosphonates-related osteonecrosis of the jaws: a preliminary study of salivary interleukins","volume":"42","author":"Bagan","year":"2013","journal-title":"J Oral Pathol Med"},{"issue":"3","key":"10.1016\/j.jormas.2025.102534_bib0014","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1021\/acs.jmedchem.0c01292","article-title":"Bisphosphonates, old friends of bones and new trends in clinics","volume":"64","author":"Barbosa","year":"2021","journal-title":"J Med Chem"},{"issue":"9","key":"10.1016\/j.jormas.2025.102534_bib0015","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"issue":"1","key":"10.1016\/j.jormas.2025.102534_bib0016","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bone.2011.01.014","article-title":"Pharmacology of bisphosphonates","volume":"49","author":"Cremers","year":"2011","journal-title":"Bone"},{"issue":"4","key":"10.1016\/j.jormas.2025.102534_bib0017","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1210\/jc.2009-1947","article-title":"Long-term use of bisphosphonates in osteoporosis","volume":"95","author":"Watts","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.jormas.2025.102534_bib0018","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.bone.2007.12.225","article-title":"Visualizing mineral binding and uptake of bisphosphonate by osteoclasts and non-resorbing cells","volume":"42","author":"Coxon","year":"2008","journal-title":"Bone"},{"issue":"6","key":"10.1016\/j.jormas.2025.102534_bib0019","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00198-007-0540-8","article-title":"Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy","volume":"19","author":"Russell","year":"2008","journal-title":"Osteoporos Int"},{"issue":"Suppl 3","key":"10.1016\/j.jormas.2025.102534_bib0020","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1007\/BF01623002","article-title":"Clinical pharmacology of alendronate sodium","volume":"3","author":"Gertz","year":"1993","journal-title":"Osteoporos Int"},{"issue":"10","key":"10.1016\/j.jormas.2025.102534_bib0021","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1359\/jbmr.1997.12.10.1700","article-title":"Elimination and biochemical responses to intravenous alendronate in postmenopausal osteoporosis","volume":"12","author":"Khan","year":"1997","journal-title":"J Bone Miner Res"},{"issue":"12","key":"10.1016\/j.jormas.2025.102534_bib0022","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1172\/JCI118722","article-title":"Bisphosphonates: mechanisms of action","volume":"97","author":"Rodan","year":"1996","journal-title":"J Clin Invest"},{"issue":"9","key":"10.1016\/j.jormas.2025.102534_bib0023","doi-asserted-by":"crossref","first-page":"4924","DOI":"10.1021\/la703381h","article-title":"Adsorption and conformational change of myoglobin on biomimetic hydroxyapatite nanocrystals functionalized with alendronate","volume":"24","author":"Iafisco","year":"2008","journal-title":"Langmuir"},{"issue":"1","key":"10.1016\/j.jormas.2025.102534_bib0024","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1210\/edrv.19.1.0325","article-title":"Bisphosphonates: mechanisms of action","volume":"19","author":"Fleisch","year":"1998","journal-title":"Endocr Rev"},{"issue":"1","key":"10.1016\/j.jormas.2025.102534_bib0025","doi-asserted-by":"crossref","first-page":"65","DOI":"10.11607\/prd.6139","article-title":"Biologic bone behavior during the osseointegration process: histologic, histomorphometric, and SEM-EDX evaluations","volume":"43","author":"Mastrangelo","year":"2023","journal-title":"Int J Periodont Restorat Dent"},{"issue":"7","key":"10.1016\/j.jormas.2025.102534_bib0026","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.1601-0825.2010.01677.x","article-title":"Effects of alendronate on bone healing after tooth extraction in rats","volume":"16","author":"Aguirre","year":"2010","journal-title":"Oral Dis"},{"issue":"1","key":"10.1016\/j.jormas.2025.102534_bib0027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ar.20619","article-title":"Bone remodeling in maxilla, mandible, and femur of young dogs","volume":"291","author":"Huja","year":"2008","journal-title":"Anat Rec"},{"issue":"1","key":"10.1016\/j.jormas.2025.102534_bib0028","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1359\/jbmr.090713","article-title":"Cancer treatment dosing regimens of zoledronic acid result in near-complete suppression of mandible intracortical bone remodeling in beagle dogs","volume":"25","author":"Allen","year":"2010","journal-title":"J Bone Miner Res"},{"issue":"3","key":"10.1016\/j.jormas.2025.102534_bib0029","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1601-0825.2007.01381.x","article-title":"Updates on bisphosphonates and potential pathobiology of bisphosphonate-induced jaw osteonecrosis","volume":"14","author":"Sarin","year":"2008","journal-title":"Oral Dis"},{"issue":"1","key":"10.1016\/j.jormas.2025.102534_bib0030","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bone.2011.04.022","article-title":"Bisphosphonates: the first 40 years","volume":"49","author":"Russell","year":"2011","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.jormas.2025.102534_bib0031","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/jbm.b.31500","article-title":"Differences between bisphosphonates in binding affinities for hydroxyapatite","volume":"92","author":"Lawson","year":"2010","journal-title":"J Biomed Mater Res B Appl Biomater"},{"issue":"8","key":"10.1016\/j.jormas.2025.102534_bib0032","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1007\/s00784-015-1706-y","article-title":"Effects of zoledronic acid and geranylgeraniol on the cellular behaviour and gene expression of primary human alveolar osteoblasts","volume":"20","author":"Zafar","year":"2016","journal-title":"Clin Oral Investig"},{"issue":"1","key":"10.1016\/j.jormas.2025.102534_bib0033","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.bone.2010.11.008","article-title":"Biochemical and molecular mechanisms of action of bisphosphonates","volume":"49","author":"Rogers","year":"2011","journal-title":"Bone"},{"issue":"9","key":"10.1016\/j.jormas.2025.102534_bib0034","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1002\/1529-0131(200109)44:9<2201::AID-ART374>3.0.CO;2-E","article-title":"The molecular mechanism of action of the antiresorptive and antiinflammatory drug clodronate: evidence for the formation in vivo of a metabolite that inhibits bone resorption and causes osteoclast and macrophage apoptosis","volume":"44","author":"Frith","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.jormas.2025.102534_bib0035","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0026-895X(24)12222-5","article-title":"Further insight into mechanism of action of clodronate: inhibition of mitochondrial ADP\/ATP translocase by a nonhydrolyzable, adenine-containing metabolite","volume":"61","author":"Lehenkari","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jormas.2025.102534_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115715","article-title":"Clodronate","volume":"143","author":"McCloskey","year":"2021","journal-title":"Bone"},{"issue":"24","key":"10.1016\/j.jormas.2025.102534_bib0037","doi-asserted-by":"crossref","first-page":"7568","DOI":"10.1021\/jacs.8b02363","article-title":"Bisphosphonate-generated ATP-analogs inhibit cell signaling pathways","volume":"140","author":"Malwal","year":"2018","journal-title":"J Am Chem Soc"},{"issue":"4","key":"10.1016\/j.jormas.2025.102534_bib0038","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/sj.bjp.0706628","article-title":"A new endogenous ATP analog (ApppI) inhibits the mitochondrial adenine nucleotide translocase (ANT) and is responsible for the apoptosis induced by nitrogen-containing bisphosphonates","volume":"147","author":"M\u00f6nkk\u00f6nen","year":"2006","journal-title":"Br J Pharmacol"},{"issue":"6","key":"10.1016\/j.jormas.2025.102534_bib0039","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S8756-3282(01)00615-9","article-title":"Inhibition of bone resorption by alendronate and risedronate does not require osteoclast apoptosis","volume":"29","author":"Halasy-Nagy","year":"2001","journal-title":"Bone"},{"issue":"3","key":"10.1016\/j.jormas.2025.102534_bib0040","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.coph.2006.03.005","article-title":"Recent advances in understanding the mechanism of action of bisphosphonates","volume":"6","author":"Coxon","year":"2006","journal-title":"Curr Opin Pharmacol"},{"issue":"6","key":"10.1016\/j.jormas.2025.102534_bib0041","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1248\/bpb.b16-01020","article-title":"Underlying mechanisms and therapeutic strategies for Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ)","volume":"40","author":"Endo","year":"2017","journal-title":"Biol Pharm Bull"},{"issue":"12","key":"10.1016\/j.jormas.2025.102534_bib0042","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/ncponc1000","article-title":"Bisphosphonates and osteomyelitis of the jaw: a pathogenic puzzle","volume":"4","author":"Bertoldo","year":"2007","journal-title":"Nat Clin Pract Oncol"},{"key":"10.1016\/j.jormas.2025.102534_bib0043","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.bonr.2018.03.003","article-title":"Bisphosphonate-related osteonecrosis of the jaw: a mechanobiology perspective","volume":"8","author":"George","year":"2018","journal-title":"Bone Rep"},{"key":"10.1016\/j.jormas.2025.102534_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172773","article-title":"Bisphosphonates-much more than only drugs for bone diseases","volume":"866","author":"Ku\u017anik","year":"2020","journal-title":"Eur J Pharmacol"},{"issue":"8","key":"10.1016\/j.jormas.2025.102534_bib0045","doi-asserted-by":"crossref","DOI":"10.1002\/jbm4.10785","article-title":"Pathophysiology of medication-related osteonecrosis of the jaw-a minireview","volume":"7","author":"Tetradis","year":"2023","journal-title":"JBMR Plus"},{"issue":"3 Suppl","key":"10.1016\/j.jormas.2025.102534_bib0046","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S1532-3382(12)70046-5","article-title":"Antiresorptives and osteonecrosis of the jaw","volume":"12","author":"Yamashita","year":"2012","journal-title":"J Evid Based Dent Pract"},{"issue":"1","key":"10.1016\/j.jormas.2025.102534_bib0047","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.bone.2011.03.774","article-title":"The relationship between the chemistry and biological activity of the bisphosphonates","volume":"49","author":"Ebetino","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.jormas.2025.102534_bib0048","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmbbm.2020.103635","article-title":"A nitrogen-containing bisphosphonate inhibits osteoblast attachment and impairs bone healing in bone-compatible scaffold","volume":"104","author":"Koyama","year":"2020","journal-title":"J Mech Behav Biomed Mater"},{"issue":"1","key":"10.1016\/j.jormas.2025.102534_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.acthis.2020.151659","article-title":"Assessment of bisphosphonate treated-osteoblast behaviors by conventional assays and a simple digital image analysis","volume":"123","author":"Patntirapong","year":"2021","journal-title":"Acta Histochem"},{"issue":"6","key":"10.1016\/j.jormas.2025.102534_bib0050","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1159\/000351194","article-title":"Zoledronic acid inhibits human osteoblast activities","volume":"59","author":"Basso","year":"2013","journal-title":"Gerontology"},{"issue":"3","key":"10.1016\/j.jormas.2025.102534_bib0051","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jcms.2014.12.008","article-title":"High doses of bisphosphonates reduce osteoblast-like cell proliferation by arresting the cell cycle and inducing apoptosis","volume":"43","author":"Manzano-Moreno","year":"2015","journal-title":"J Craniomaxillofac Surg"},{"issue":"1","key":"10.1016\/j.jormas.2025.102534_bib0052","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.bone.2003.08.013","article-title":"The nitrogen-containing bisphosphonate, zoledronic acid, increases mineralisation of human bone-derived cells in vitro","volume":"34","author":"Pan","year":"2004","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.jormas.2025.102534_bib0053","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1177\/147323000903700216","article-title":"Effects of alendronate on the proliferation and osteogenic differentiation of MG-63 cells","volume":"37","author":"Xiong","year":"2009","journal-title":"J Int Med Res"},{"issue":"11","key":"10.1016\/j.jormas.2025.102534_bib0054","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1359\/jbmr.2001.16.11.2050","article-title":"Extracellular signal-regulated kinases and calcium channels are involved in the proliferative effect of bisphosphonates on osteoblastic cells in vitro","volume":"16","author":"Mathov","year":"2001","journal-title":"J Bone Miner Res"},{"issue":"12","key":"10.1016\/j.jormas.2025.102534_bib0055","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1007\/s11999-008-0409-y","article-title":"Alendronate enhances osteogenic differentiation of bone marrow stromal cells: a preliminary study","volume":"467","author":"Kim","year":"2009","journal-title":"Clin Orthop Relat Res"},{"issue":"18","key":"10.1016\/j.jormas.2025.102534_bib0056","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1016\/j.biomaterials.2003.11.024","article-title":"Osteoblast proliferation and maturation by bisphosphonates","volume":"25","author":"Im","year":"2004","journal-title":"Biomaterials"},{"issue":"34","key":"10.1016\/j.jormas.2025.102534_bib0057","doi-asserted-by":"crossref","first-page":"6941","DOI":"10.1016\/j.biomaterials.2005.04.059","article-title":"Effects of bisphosphonates on proliferation and osteoblast differentiation of human bone marrow stromal cells","volume":"26","author":"von Knoch","year":"2005","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.jormas.2025.102534_bib0058","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3892\/mmr.2015.4627","article-title":"Dose-dependent inhibitory effects of zoledronic acid on osteoblast viability and function in vitro","volume":"13","author":"Huang","year":"2016","journal-title":"Mol Med Rep"},{"issue":"1","key":"10.1016\/j.jormas.2025.102534_bib0059","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.bone.2010.08.008","article-title":"Novel actions of bisphosphonates in bone: preservation of osteoblast and osteocyte viability","volume":"49","author":"Bellido","year":"2011","journal-title":"Bone"},{"issue":"12","key":"10.1016\/j.jormas.2025.102534_bib0060","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1111\/clr.12492","article-title":"Effects of the long-term administration of alendronate on the mechanical properties of the basal bone and on osseointegration","volume":"26","author":"Verzola","year":"2015","journal-title":"Clin Oral Implants Res"},{"issue":"7","key":"10.1016\/j.jormas.2025.102534_bib0061","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/clr.13602","article-title":"Rares Ciprian Benea H. Tibolone, alendronate, and simvastatin enhance implant osseointegration in a preclinical in vivo model","volume":"31","author":"Apostu","year":"2020","journal-title":"Clin Oral Implants Res"},{"issue":"4","key":"10.1016\/j.jormas.2025.102534_bib0062","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/jor.24853","article-title":"Alendronate enhances osseointegration in a murine implant model","volume":"39","author":"Vertesich","year":"2021","journal-title":"J Orthop Res"},{"issue":"12","key":"10.1016\/j.jormas.2025.102534_bib0063","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1002\/jor.24125","article-title":"Local delivery of a zoledronate solution improves osseointegration of titanium implants in a rat distal femur model","volume":"36","author":"AbuMoussa","year":"2018","journal-title":"J Orthop Res"},{"issue":"7","key":"10.1016\/j.jormas.2025.102534_bib0064","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1007\/s00198-013-2288-7","article-title":"Zoledronic acid enhances bone-implant osseointegration more than alendronate and strontium ranelate in ovariectomized rats","volume":"24","author":"Chen","year":"2013","journal-title":"Osteoporos Int"},{"issue":"3","key":"10.1016\/j.jormas.2025.102534_bib0065","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.joms.2006.10.076","article-title":"Resolution of bisphosphonate-associated osteonecrosis of the mandible: possible application for intermittent low-dose parathyroid hormone [rhPTH(1-34)]","volume":"65","author":"Harper","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"issue":"3","key":"10.1016\/j.jormas.2025.102534_bib0066","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S8756-3282(00)00448-8","article-title":"Bone tissue and its mineralization in aged estrogen-depleted rats after long-term intermittent treatment with parathyroid hormone (PTH) analog SDZ PTS 893 or human PTH(1-34)","volume":"28","author":"Kneissel","year":"2001","journal-title":"Bone"},{"issue":"11","key":"10.1016\/j.jormas.2025.102534_bib0067","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1007\/s00198-005-1876-6","article-title":"Intermittently administered parathyroid hormone 1-34 reverses bone loss and structural impairment in orchiectomized adult rats","volume":"16","author":"Gabet","year":"2005","journal-title":"Osteoporos Int"},{"issue":"2","key":"10.1016\/j.jormas.2025.102534_bib0068","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.bone.2006.02.004","article-title":"Parathyroid hormone 1-34 enhances titanium implant anchorage in low-density trabecular bone: a correlative micro-computed tomographic and biomechanical analysis","volume":"39","author":"Gabet","year":"2006","journal-title":"Bone"},{"issue":"4","key":"10.1016\/j.jormas.2025.102534_bib0069","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1053\/joms.2003.50093","article-title":"Effect of intermittent parathyroid hormone (1-34) treatment on the bone response after placement of titanium implants into the tibia of ovariectomized rats","volume":"61","author":"Shirota","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"issue":"3","key":"10.1016\/j.jormas.2025.102534_bib0070","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s00198-012-2258-5","article-title":"Promotion of peri-implant bone healing by systemically administered parathyroid hormone (1-34) and zoledronic acid adsorbed onto the implant surface","volume":"24","author":"Li","year":"2013","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jormas.2025.102534_bib0071","doi-asserted-by":"crossref","first-page":"333","DOI":"10.22203\/eCM.v037a20","article-title":"Systemic sclerostin antibody treatment increases osseointegration and biomechanical competence of zoledronic-acid-coated dental implants in a rat osteoporosis model","volume":"37","author":"Korn","year":"2019","journal-title":"Eur Cell Mater"},{"key":"10.1016\/j.jormas.2025.102534_bib0072","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bone.2016.10.007","article-title":"Role and mechanism of action of sclerostin in bone","volume":"96","author":"Delgado-Calle","year":"2017","journal-title":"Bone"},{"key":"10.1016\/j.jormas.2025.102534_bib0073","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.bone.2016.10.019","article-title":"Effects of sclerostin antibodies in animal models of osteoporosis","volume":"96","author":"Ominsky","year":"2017","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.jormas.2025.102534_bib0074","doi-asserted-by":"crossref","first-page":"170","DOI":"10.4012\/dmj.26.170","article-title":"Development of new drug delivery system for implant bone augmentation using a basic fibroblast growth factor-gelatin hydrogel complex","volume":"26","author":"Hayashi","year":"2007","journal-title":"Dent Mater J"},{"issue":"25","key":"10.1016\/j.jormas.2025.102534_bib0075","doi-asserted-by":"crossref","first-page":"4603","DOI":"10.1016\/S0142-9612(03)00354-5","article-title":"Bone ingrowth in bFGF-coated hydroxyapatite ceramic implants","volume":"24","author":"Schnettler","year":"2003","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.jormas.2025.102534_bib0076","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.bone.2008.10.054","article-title":"Effect of combined local treatment with zoledronic acid and basic fibroblast growth factor on implant fixation in ovariectomized rats","volume":"44","author":"Gao","year":"2009","journal-title":"Bone"},{"issue":"5","key":"10.1016\/j.jormas.2025.102534_bib0077","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.tripleo.2009.10.041","article-title":"Additive effects of estrogen replacement therapy and bisphosphonates on osseointegration of hydroxyapatite-coated titanium screws in ovariectomized rats","volume":"109","author":"Li","year":"2010","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.jormas.2025.102534_bib0078","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.actbio.2024.03.005","article-title":"Systemically administered zoledronic acid activates locally implanted synthetic hydroxyapatite particles enhancing peri-implant bone formation: a regenerative medicine approach to improve fracture fixation","volume":"179","author":"Markeviciute","year":"2024","journal-title":"Acta Biomater"},{"issue":"2","key":"10.1016\/j.jormas.2025.102534_bib0079","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1620\/tjem.247.75","article-title":"Antiresorptive Agent-Related Osteonecrosis of the Jaw (ARONJ): a Twist of Fate in the Bone","volume":"247","author":"Shibahara","year":"2019","journal-title":"Tohoku J Exp Med"},{"key":"10.1016\/j.jormas.2025.102534_bib0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2019.146469","article-title":"Dexamethasone impairs neurofunctional recovery in rats following traumatic brain injury by reducing circulating endothelial progenitor cells and angiogenesis","volume":"1725","author":"Zhang","year":"2019","journal-title":"Brain Res"},{"issue":"1","key":"10.1016\/j.jormas.2025.102534_bib0081","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-96050-2","article-title":"Dexamethasone: a double-edged sword in the treatment of osteoarthritis","volume":"15","author":"Tarasova","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.jormas.2025.102534_bib0082","doi-asserted-by":"crossref","DOI":"10.1097\/SCS.0000000000010412","article-title":"Investigation of the effect of local and systemic preoperative dexamethasone application on bone tissue healing in mandibular bone defects","author":"Yavuz","year":"2024","journal-title":"J Craniofac Surg"},{"issue":"1","key":"10.1016\/j.jormas.2025.102534_bib0083","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1186\/s12967-025-06528-w","article-title":"Injectable nanocomposite hydrogel for localized precision delivery of dexamethasone after traumatic brain injury: dual modulation of neuroinflammation and blood-brain barrier restoration","volume":"23","author":"Zhang","year":"2025","journal-title":"J Transl Med"},{"key":"10.1016\/j.jormas.2025.102534_bib0084","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2021.115942","article-title":"Alendronate\/dexamethasone combination therapy worsens soft and hard tissue wound healing around implants in rat maxillae","volume":"148","author":"Inoue","year":"2021","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.jormas.2025.102534_bib0085","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3390\/dj5010002","article-title":"Angiogenesis in the development of medication-related osteonecrosis of the jaws: an overview","volume":"5","author":"Pabst","year":"2016","journal-title":"Dent J"},{"issue":"4","key":"10.1016\/j.jormas.2025.102534_bib0086","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1007\/s00784-018-2579-7","article-title":"Immediate implant placement following 1-year treatment with oral versus intravenous bisphosphonates: a histomorphometric canine study on peri-implant bone","volume":"23","author":"Khojasteh","year":"2019","journal-title":"Clin Oral Investig"},{"issue":"4","key":"10.1016\/j.jormas.2025.102534_bib0087","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1007\/s00784-018-2612-x","article-title":"Evaluation of bone turnover after bisphosphonate withdrawal and its influence on implant osseointegration: an in vivo study in rats","volume":"23","author":"Frizzera","year":"2019","journal-title":"Clin Oral Investig"},{"issue":"5","key":"10.1016\/j.jormas.2025.102534_bib0088","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.11607\/jomi.2685","article-title":"The effect of systemically administered bisphosphonates on bony healing after tooth extraction and osseointegration of dental implants in the rabbit maxilla","volume":"28","author":"Kim","year":"2013","journal-title":"Int J Oral Maxillofac Implants"},{"issue":"5","key":"10.1016\/j.jormas.2025.102534_bib0089","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/JPER.19-0213","article-title":"Aminobisphosphonate-treated ewes as a model of osteonecrosis of the jaw and of dental implant failure","volume":"91","author":"Davison","year":"2020","journal-title":"J Periodontol"},{"issue":"5","key":"10.1016\/j.jormas.2025.102534_bib0090","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/j.1365-2141.2008.07504.x","article-title":"Effect of zoledronic acid on oral fibroblasts and epithelial cells: a potential mechanism of bisphosphonate-associated osteonecrosis","volume":"144","author":"Scheper","year":"2009","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.jormas.2025.102534_bib0091","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.archoralbio.2010.11.003","article-title":"Bisphosphonate effects on the behaviour of oral epithelial cells and oral fibroblasts","volume":"56","author":"Ravosa","year":"2011","journal-title":"Arch Oral Biol"},{"issue":"6","key":"10.1016\/j.jormas.2025.102534_bib0092","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1177\/0022034511402995","article-title":"Bisphosphonates induce senescence in normal human oral keratinocytes","volume":"90","author":"Kim","year":"2011","journal-title":"J Dent Res"},{"issue":"5","key":"10.1016\/j.jormas.2025.102534_bib0093","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/odi.12154","article-title":"Alendronate impairs epithelial adhesion, differentiation and proliferation in human oral mucosa","volume":"20","author":"Donetti","year":"2014","journal-title":"Oral Dis"},{"issue":"2","key":"10.1016\/j.jormas.2025.102534_bib0094","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00774-009-0128-9","article-title":"Zoledronic acid delays wound healing of the tooth extraction socket, inhibits oral epithelial cell migration, and promotes proliferation and adhesion to hydroxyapatite of oral bacteria, without causing osteonecrosis of the jaw, in mice","volume":"28","author":"Kobayashi","year":"2010","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.jormas.2025.102534_bib0095","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1104826","article-title":"Zoledronic acid affects the process of Porphyromonas gingivalis infecting oral mucosal epithelial barrier: an in-vivo and in-vitro study","volume":"13","author":"Sun","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"issue":"4","key":"10.1016\/j.jormas.2025.102534_bib0096","first-page":"289","article-title":"Bisphosphonates: clinical applications and adverse events in dentistry","volume":"13","author":"Polymeri","year":"2015","journal-title":"Oral Health N Hav Prev Dent"},{"key":"10.1016\/j.jormas.2025.102534_bib0097","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2021.115933","article-title":"Bisphosphonates in dentistry: historical perspectives, adverse effects, and novel applications","volume":"147","author":"Sedghizadeh","year":"2021","journal-title":"Bone"},{"issue":"5","key":"10.1016\/j.jormas.2025.102534_bib0098","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.joms.2009.07.079","article-title":"Bisphosphonate-related osteonecrosis of the jaw: is pH the missing part in the pathogenesis puzzle?","volume":"68","author":"Otto","year":"2010","journal-title":"J Oral Maxillofac Surg"},{"issue":"1","key":"10.1016\/j.jormas.2025.102534_bib0099","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12903-020-01089-4","article-title":"Effect of bisphosphonate treatment of titanium surfaces on alkaline phosphatase activity in osteoblasts: a systematic review and meta-analysis","volume":"20","author":"Wehner","year":"2020","journal-title":"BMC Oral Health N Hav"},{"issue":"1","key":"10.1016\/j.jormas.2025.102534_bib0100","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/clr.13391","article-title":"Impact of a zoledronate coating on early post-surgical implant stability and marginal bone resorption in the maxilla-A split-mouth randomized clinical trial","volume":"30","author":"Abtahi","year":"2019","journal-title":"Clin Oral Implants Res"},{"issue":"12","key":"10.1016\/j.jormas.2025.102534_bib0101","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.ijom.2016.09.001","article-title":"Randomised trial of bisphosphonate-coated dental implants: radiographic follow-up after five years of loading","volume":"45","author":"Abtahi","year":"2016","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"Suppl 1","key":"10.1016\/j.jormas.2025.102534_bib0102","first-page":"e168","article-title":"The topical administration of bisphosphonates in implant surgery: a randomized split-mouth prospective study with a follow-up up to 5 years","volume":"17","author":"Zuffetti","year":"2015","journal-title":"Clin Implant Dent Relat Res"},{"issue":"9","key":"10.1016\/j.jormas.2025.102534_bib0103","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1007\/s00198-019-05257-3","article-title":"Effects of anti-resorptive drugs on implant survival and peri-implantitis in patients with existing osseointegrated dental implants: a retrospective cohort study","volume":"31","author":"Kim","year":"2020","journal-title":"Osteoporos Int"},{"issue":"7","key":"10.1016\/j.jormas.2025.102534_bib0104","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.3390\/jcm13072091","article-title":"Effect of antiresorptive drugs on osseointegrated dental implants: a systematic review","volume":"13","author":"Li","year":"2024","journal-title":"J Clin Med"},{"issue":"15","key":"10.1016\/j.jormas.2025.102534_bib0105","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.3390\/cells11152308","article-title":"Bone Disease in Multiple Myeloma: biologic and Clinical Implications","volume":"11","author":"Bernstein","year":"2022","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.jormas.2025.102534_bib0106","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jdsr.2018.09.002","article-title":"Novel insight into the management of bisphosphonate-related osteonecrosis of the jaw (BRONJ)","volume":"55","author":"Kishimoto","year":"2019","journal-title":"Jpn Dent Sci Rev"},{"issue":"1","key":"10.1016\/j.jormas.2025.102534_bib0107","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.2405","article-title":"International Task Force on Osteonecrosis of the Jaw. Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus","volume":"30","author":"Khan","year":"2015","journal-title":"J Bone Miner Res"},{"issue":"18","key":"10.1016\/j.jormas.2025.102534_bib0108","doi-asserted-by":"crossref","first-page":"6078","DOI":"10.3390\/ma16186078","article-title":"Bisphosphonates and dental implants: a systematic review and meta-analysis","volume":"16","author":"Sulaiman","year":"2023","journal-title":"Materials"},{"issue":"22","key":"10.1016\/j.jormas.2025.102534_bib0109","doi-asserted-by":"crossref","first-page":"5366","DOI":"10.3390\/cancers15225366","article-title":"Bisphosphonates and their connection to dental procedures: exploring bisphosphonate-related osteonecrosis of the jaws","volume":"15","author":"Lee","year":"2023","journal-title":"Cancers"},{"issue":"10","key":"10.1016\/j.jormas.2025.102534_bib0110","article-title":"Enhancing the oral rehabilitation and quality of life of bisphosphonate-treated patients: the role of dental implants","volume":"15","author":"Altalhi","year":"2023","journal-title":"Cureus"},{"issue":"Suppl 16","key":"10.1016\/j.jormas.2025.102534_bib0111","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/clr.13137","article-title":"Medication-related dental implant failure: systematic review and meta-analysis","volume":"29","author":"Chappuis","year":"2018","journal-title":"Clin Oral Implants Res"},{"issue":"3","key":"10.1016\/j.jormas.2025.102534_bib0112","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1097\/SCS.0000000000001535","article-title":"Failure risk estimates after dental implants placement associated with plasma rich in growth factor-Endoret in osteoporotic women under bisphosphonate therapy","volume":"26","author":"Mozzati","year":"2015","journal-title":"J Craniofac Surg"},{"issue":"9","key":"10.1016\/j.jormas.2025.102534_bib0113","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.3390\/ma15093227","article-title":"Diabetes Mellitus and Dental Implants: a Systematic Review and Meta-Analysis","volume":"15","author":"Al Ansari","year":"2022","journal-title":"Materials"},{"issue":"1","key":"10.1016\/j.jormas.2025.102534_bib0114","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3390\/medicina58010039","article-title":"Smoking and Dental Implants: a Systematic Review and Meta-Analysis","volume":"58","author":"Mustapha","year":"2021","journal-title":"Medicina"},{"issue":"Suppl 26","key":"10.1016\/j.jormas.2025.102534_bib0115","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/clr.14135","article-title":"Group 3 ITI Consensus Report: materials and antiresorptive drug-associated outcomes in implant dentistry","volume":"34","author":"Al-Nawas","year":"2023","journal-title":"Clin Oral Implants Res"},{"issue":"1","key":"10.1016\/j.jormas.2025.102534_bib0116","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/prd.12518","article-title":"Bone regeneration in implant dentistry: which are the factors affecting the clinical outcome?","volume":"93","author":"Donos","year":"2023","journal-title":"Periodontol 2000"},{"key":"10.1016\/j.jormas.2025.102534_bib0117","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5571793","article-title":"Use of Narrow-Diameter Implants in Completely Edentulous Patients as a Prosthetic Option: a Systematic Review of the Literature","volume":"2021","author":"Storelli","year":"2021","journal-title":"Biomed Res Int"},{"issue":"4","key":"10.1016\/j.jormas.2025.102534_bib0118","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/cid.12769","article-title":"The All-on-4 treatment concept for the rehabilitation of the completely edentulous mandible: a longitudinal study with 10 to 18 years of follow-up","volume":"21","author":"Mal\u00f3","year":"2019","journal-title":"Clin Implant Dent Relat Res"},{"issue":"2","key":"10.1016\/j.jormas.2025.102534_bib0119","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.oooo.2018.09.008","article-title":"Medication-related osteonecrosis of the jaw: definition and best practice for prevention, diagnosis, and treatment","volume":"127","author":"Nicolatou-Galitis","year":"2019","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"5","key":"10.1016\/j.jormas.2025.102534_bib0120","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.joms.2022.02.008","article-title":"American Association of Oral and Maxillofacial Surgeons' Position Paper on Medication-Related Osteonecrosis of the Jaws-2022 Update","volume":"80","author":"Ruggiero","year":"2022","journal-title":"J Oral Maxillofac Surg"},{"issue":"2","key":"10.1016\/j.jormas.2025.102534_bib0121","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1563\/aaid-joi-D-19-00088","article-title":"Success rate and safety of dental implantology in patients treated with antiresorptive medication: a systematic review","volume":"47","author":"Papadakis","year":"2021","journal-title":"J Oral Implantol"},{"issue":"1","key":"10.1016\/j.jormas.2025.102534_bib0122","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/prd.12440","article-title":"Minimal invasiveness at dental implant placement: a systematic review with meta-analyses on flapless fully guided surgery","volume":"91","author":"Romandini","year":"2023","journal-title":"Periodontol"},{"issue":"6","key":"10.1016\/j.jormas.2025.102534_bib0123","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/jcpe.13795","article-title":"Immediate implant placement with flap or flapless surgery: a systematic review and meta-analysis","volume":"50","author":"Pitman","year":"2023","journal-title":"J Clin Periodontol"},{"issue":"10","key":"10.1016\/j.jormas.2025.102534_bib0124","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202004572","article-title":"N-Doped Carbon Nanotubes Derived from Graphene Oxide with Embedment of FeCo Nanoparticles as Bifunctional Air Electrode for Rechargeable Liquid and Flexible All-Solid-State Zinc-Air Batteries","volume":"8","author":"Hao","year":"2021","journal-title":"Adv Sci"},{"key":"10.1016\/j.jormas.2025.102534_bib0125","article-title":"Bisphosphonate-incorporated coatings for orthopedic implants functionalization","volume":"22","author":"Zhang","year":"2023","journal-title":"Mater Today Bio"},{"key":"10.1016\/j.jormas.2025.102534_bib0126","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmbbm.2024.106661","article-title":"Dual-functional Hydroxyapatite scaffolds for bone regeneration and precision drug delivery","volume":"157","author":"Farazin","year":"2024","journal-title":"J Mech Behav Biomed Mater"},{"issue":"17","key":"10.1016\/j.jormas.2025.102534_bib0127","article-title":"Biopolymer-based coatings: promising strategies to improve the biocompatibility and functionality of materials used in biomedical engineering","volume":"7","author":"Song","year":"2020","journal-title":"Adv. Mater. Interfac."},{"issue":"2","key":"10.1016\/j.jormas.2025.102534_bib0128","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ijvsm.2018.08.003","article-title":"Microwave assisted green synthesis of Hydroxyapatite nanorods using Moringa oleifera flower extract and its antimicrobial applications","volume":"6","author":"Kalaiselvi","year":"2018","journal-title":"Int J Vet Sci Med"},{"issue":"6","key":"10.1016\/j.jormas.2025.102534_bib0129","doi-asserted-by":"crossref","first-page":"568","DOI":"10.3390\/coatings10060568","article-title":"Customized therapeutic surface coatings for dental implants","volume":"10","author":"Zafar","year":"2020","journal-title":"Coatings"},{"issue":"21","key":"10.1016\/j.jormas.2025.102534_bib0130","doi-asserted-by":"crossref","first-page":"5482","DOI":"10.1016\/j.biomaterials.2014.03.069","article-title":"Synergistic effects of bisphosphonate and calcium phosphate nanoparticles on peri-implant bone responses in osteoporotic rats","volume":"35","author":"Alghamdi","year":"2014","journal-title":"Biomaterials"},{"issue":"11","key":"10.1016\/j.jormas.2025.102534_bib0131","doi-asserted-by":"crossref","first-page":"6439","DOI":"10.1039\/C5SC01767J","article-title":"In vivo study and thermodynamic investigation of two lanthanum complexes, La(dpp)3 and La(XT), for the treatment of bone resorption disorders","volume":"6","author":"Cawthray","year":"2015","journal-title":"Chem Sci"},{"key":"10.1016\/j.jormas.2025.102534_bib0132","article-title":"SENP3-Mediated PPAR\u03b32 DeSUMOylation in BM-MSCs Potentiates Glucocorticoid-Induced Osteoporosis by Promoting Adipogenesis and Weakening Osteogenesis","volume":"9","author":"Zhang","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.jormas.2025.102534_bib0133","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.addr.2015.05.013","article-title":"MicroRNA-mediated immune modulation as a therapeutic strategy in host-implant integration","volume":"88","author":"Ong","year":"2015","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.jormas.2025.102534_bib0134","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2021.115942","article-title":"Alendronate\/dexamethasone combination therapy worsens soft and hard tissue wound healing around implants in rat maxillae","volume":"148","author":"Inoue","year":"2021","journal-title":"Bone"},{"issue":"7","key":"10.1016\/j.jormas.2025.102534_bib0135","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/JPER.20-0547","article-title":"Microstructural volumetric analysis of the jaw following dental implantation under systemic bisphosphonate delivery: an in vivo and ex vivo rat study","volume":"92","author":"Kniha","year":"2021","journal-title":"J Periodontol"},{"key":"10.1016\/j.jormas.2025.102534_bib0136","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.reth.2018.10.008","article-title":"Allogeneic multipotent mesenchymal stromal cell sheet transplantation promotes healthy healing of wounds caused by zoledronate and dexamethasone in canine mandibular bones","volume":"10","author":"Kaibuchi","year":"2019","journal-title":"Regen Ther."},{"issue":"7","key":"10.1016\/j.jormas.2025.102534_bib0137","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/j.1601-0825.2011.01829.x","article-title":"Effect of alendronate on healing of extraction sockets and healing around implants","volume":"17","author":"Kim","year":"2011","journal-title":"Oral Dis"},{"issue":"1","key":"10.1016\/j.jormas.2025.102534_bib0138","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/s41598-023-49647-4","article-title":"Peri-implantitis increases the risk of medication-related osteonecrosis of the jaws associated with osseointegrated implants in rats treated with zoledronate","volume":"14","author":"Quint\u00e3o Manhanini Souza","year":"2024","journal-title":"Sci Rep"}],"container-title":["Journal of Stomatology Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468785525003209?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468785525003209?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T00:37:34Z","timestamp":1763858254000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468785525003209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":138,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2468785525003209"],"URL":"https:\/\/doi.org\/10.1016\/j.jormas.2025.102534","relation":{},"ISSN":["2468-7855"],"issn-type":[{"value":"2468-7855","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual effects of bisphosphonates on bone metabolism and implant osseointegration: mechanisms, risks and clinical strategies","name":"articletitle","label":"Article Title"},{"value":"Journal of Stomatology Oral and Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jormas.2025.102534","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"102534"}}